logo

Achieve Life Sciences Inc. (ACHV)



Trade ACHV now with
  Date
  Headline
3/14/2019 4:14:37 PM Achieve Life Sciences Q4 Loss/share $0.55 Vs. Loss $3.17 Year Ago
2/22/2019 5:52:07 AM Achieve Says Final Data From Cytisinicline Phase I/II Multi-Dose PK/PD Clinical Study To Be Presented At SRNT Meeting
2/20/2019 5:31:12 AM Achieve Life Sciences Completes Enrollment In 254-Subject Phase 2b Trial Of Cytisinicline For Smoking Cessation
12/18/2018 5:32:31 AM Achieve Announces Update On Cytisinicline Clinical Development Program
10/30/2018 5:53:56 AM Achieve Life Sciences Begins Phase 2b ORCA-1 Trial Of Cytisinicline For Smoking Cessation
10/1/2018 9:09:43 AM Achieve Life Sciences Announces Pricing Of $5.6 Mln Registered Direct Offering
9/27/2018 5:37:21 AM Achieve Reports Results Of Clinical Study On Effect Of Food On Bioavailability Of New Formulation For Cytisine
9/18/2018 5:32:38 AM Achieve Life Sciences Reports Positive Cytisine Data Published In International Journal Of Drug Policy
9/6/2018 5:34:57 AM Achieve Life Sciences Announces Cytisine Data Presented At SRNT-E Annual Conference
7/11/2018 5:32:07 AM Achieve Life Sciences Announces Update On Cytisine Development Program Following Meeting Conducted With FDA
6/26/2018 5:36:40 AM Achieve Life Sciences Reports Positive Cytisine Data Showing No Clinically Significant Drug-Drug Interaction
6/15/2018 8:31:06 AM Achieve Life Sciences Announces Pricing Of $12 Mln Underwritten Public Offering